Business Description
Sinotherapeutics Inc
ISIN : CNE100005PL9
Share Class Description:
SHSE:688247: Class ATotal Employee Number:
319Compare
Compare
Traded in other countries / regions
688247.China Index Membership
SSE Composite Index IPO Date
2022-08-25Description
Sinotherapeutics Inc is engaged in the research and development, production, and sales of generic drugs and CRO services.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 111048.57 | |||||
Equity-to-Asset | 0.9 | |||||
Interest Coverage | 12.78 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 16.73 | |||||
Beneish M-Score | -2.21 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.9 | |||||
3-Year EBITDA Growth Rate | -12.5 | |||||
3-Year EPS without NRI Growth Rate | -27 | |||||
3-Year Book Growth Rate | 3.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.22 | |||||
9-Day RSI | 36.15 | |||||
14-Day RSI | 42.22 | |||||
3-1 Month Momentum % | -16.59 | |||||
6-1 Month Momentum % | -28.87 | |||||
12-1 Month Momentum % | -35.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.98 | |||||
Quick Ratio | 10.24 | |||||
Cash Ratio | 8.94 | |||||
Days Inventory | 119.68 | |||||
Days Sales Outstanding | 62.72 | |||||
Days Payable | 33.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.42 | |||||
Dividend Payout Ratio | 0.46 | |||||
Forward Dividend Yield % | 0.42 | |||||
5-Year Yield-on-Cost % | 0.42 | |||||
Shareholder Yield % | 0.43 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.19 | |||||
Operating Margin % | 12.84 | |||||
Net Margin % | 10.08 | |||||
EBITDA Margin % | 11.21 | |||||
FCF Margin % | 8.93 | |||||
OCF Margin % | 16.18 | |||||
ROE % | 3.35 | |||||
ROA % | 3 | |||||
ROIC % | 7.69 | |||||
3-Year ROIIC % | -9.14 | |||||
ROC (Joel Greenblatt) % | 10.32 | |||||
ROCE % | 3.54 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 84.8 | |||||
PE Ratio without NRI | 62.81 | |||||
PS Ratio | 8.38 | |||||
PB Ratio | 2.93 | |||||
Price-to-Tangible-Book | 3.01 | |||||
Price-to-Free-Cash-Flow | 82.34 | |||||
Price-to-Operating-Cash-Flow | 48.19 | |||||
EV-to-EBIT | 60.52 | |||||
EV-to-EBITDA | 60.52 | |||||
EV-to-Revenue | 6.78 | |||||
EV-to-FCF | 75.98 | |||||
Price-to-GF-Value | 0.74 | |||||
Price-to-Graham-Number | 2.9 | |||||
| Price-to-Net-Current-Asset-Value | 4.74 | |||||
| Price-to-Net-Cash | 6.11 | |||||
Earnings Yield (Greenblatt) % | 1.65 | |||||
FCF Yield % | 1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinotherapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 432.189 | ||
| EPS (TTM) (Â¥) | 0.1 | ||
| Beta | 0.9555 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.75 | ||
| Volatility % | 32.56 | ||
| 14-Day RSI | 42.22 | ||
| 14-Day ATR (Â¥) | 0.51296 | ||
| 20-Day SMA (Â¥) | 8.8235 | ||
| 12-1 Month Momentum % | -35.9 | ||
| 52-Week Range (Â¥) | 7.02 - 13.28 | ||
| Shares Outstanding (Mil) | 453.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinotherapeutics Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.010000 Cash Dividend | 2026-06-26 | 7.54 (-0.92%) | ||
| CNY 0.025000 Cash Dividend | 2025-10-21 | 10.50 (-0.10%) | ||
| CNY 0.037000 Cash Dividend | 2025-06-27 | 10.12 (+0.00%) | ||
| CNY 0.025000 Cash Dividend | 2024-10-25 | 9.81 (+1.24%) |
Show
Entries
Sinotherapeutics Inc Frequently Asked Questions
What is Sinotherapeutics Inc(SHSE:688247)'s stock price today?
The current price of SHSE:688247 is ¥8.48. The 52 week high of SHSE:688247 is ¥13.28 and 52 week low is ¥7.02.
When is next earnings date of Sinotherapeutics Inc(SHSE:688247)?
The next earnings date of Sinotherapeutics Inc(SHSE:688247) is .
Does Sinotherapeutics Inc(SHSE:688247) pay dividends? If so, how much?
The Dividend Yield %  of Sinotherapeutics Inc(SHSE:688247) is 0.42% (As of Today), Highest Dividend Payout Ratio of Sinotherapeutics Inc(SHSE:688247) was 0.89. The lowest was 0.26. And the median was 0.62. The  Forward Dividend Yield % of Sinotherapeutics Inc(SHSE:688247) is 0.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sinotherapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers